Logo image of BX

BLACKSTONE INC (BX) Stock Fundamental Analysis

NYSE:BX - New York Stock Exchange, Inc. - US09260D1072 - Common Stock - Currency: USD

144.2  -1.25 (-0.86%)

After market: 144.2 0 (0%)

Fundamental Rating

5

BX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 230 industry peers in the Capital Markets industry. BX scores excellent on profitability, but there are concerns on its financial health. BX is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BX had positive earnings in the past year.
BX had a positive operating cash flow in the past year.
Each year in the past 5 years BX has been profitable.
Each year in the past 5 years BX had a positive operating cash flow.
BX Yearly Net Income VS EBIT VS OCF VS FCFBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

BX's Return On Assets of 5.62% is fine compared to the rest of the industry. BX outperforms 72.17% of its industry peers.
With an excellent Return On Equity value of 31.89%, BX belongs to the best of the industry, outperforming 96.09% of the companies in the same industry.
The Return On Invested Capital of BX (16.42%) is better than 93.04% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BX is significantly above the industry average of 7.27%.
The 3 year average ROIC (12.81%) for BX is below the current ROIC(16.42%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.62%
ROE 31.89%
ROIC 16.42%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
BX Yearly ROA, ROE, ROICBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

Looking at the Profit Margin, with a value of 19.83%, BX is in line with its industry, outperforming 58.26% of the companies in the same industry.
BX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 49.58%, BX belongs to the top of the industry, outperforming 88.70% of the companies in the same industry.
BX's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 49.58%
PM (TTM) 19.83%
GM N/A
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
BX Yearly Profit, Operating, Gross MarginsBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The number of shares outstanding for BX has been increased compared to 1 year ago.
The number of shares outstanding for BX has been increased compared to 5 years ago.
The debt/assets ratio for BX has been reduced compared to a year ago.
BX Yearly Shares OutstandingBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BX Yearly Total Debt VS Total AssetsBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

BX has an Altman-Z score of 3.52. This indicates that BX is financially healthy and has little risk of bankruptcy at the moment.
BX has a Altman-Z score of 3.52. This is in the better half of the industry: BX outperforms 79.13% of its industry peers.
The Debt to FCF ratio of BX is 3.48, which is a good value as it means it would take BX, 3.48 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.48, BX is in the better half of the industry, outperforming 73.04% of the companies in the same industry.
A Debt/Equity ratio of 1.56 is on the high side and indicates that BX has dependencies on debt financing.
BX has a worse Debt to Equity ratio (1.56) than 72.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 3.48
Altman-Z 3.52
ROIC/WACCN/A
WACCN/A
BX Yearly LT Debt VS Equity VS FCFBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 0.71 indicates that BX may have some problems paying its short term obligations.
With a Current ratio value of 0.71, BX is not doing good in the industry: 67.83% of the companies in the same industry are doing better.
A Quick Ratio of 0.71 indicates that BX may have some problems paying its short term obligations.
BX has a Quick ratio of 0.71. This is in the lower half of the industry: BX underperforms 67.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.71
BX Yearly Current Assets VS Current LiabilitesBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

7

3. Growth

3.1 Past

BX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.95%, which is quite good.
BX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.97% yearly.
The Revenue has grown by 24.23% in the past year. This is a very strong growth!
Measured over the past years, BX shows a quite strong growth in Revenue. The Revenue has been growing by 12.51% on average per year.
EPS 1Y (TTM)19.95%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%11.22%
Revenue 1Y (TTM)24.23%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%8.41%

3.2 Future

Based on estimates for the next years, BX will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.46% on average per year.
Based on estimates for the next years, BX will show a quite strong growth in Revenue. The Revenue will grow by 15.92% on average per year.
EPS Next Y7.48%
EPS Next 2Y19.17%
EPS Next 3Y21.17%
EPS Next 5Y14.46%
Revenue Next Year6.31%
Revenue Next 2Y17.04%
Revenue Next 3Y19.15%
Revenue Next 5Y15.92%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BX Yearly Revenue VS EstimatesBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BX Yearly EPS VS EstimatesBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.36, the valuation of BX can be described as expensive.
70.43% of the companies in the same industry are cheaper than BX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.60, BX is valued at the same level.
A Price/Forward Earnings ratio of 21.88 indicates a rather expensive valuation of BX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BX indicates a slightly more expensive valuation: BX is more expensive than 60.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BX to the average of the S&P500 Index (22.43), we can say BX is valued inline with the index average.
Industry RankSector Rank
PE 30.36
Fwd PE 21.88
BX Price Earnings VS Forward Price EarningsBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

65.65% of the companies in the same industry are more expensive than BX, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as BX.
Industry RankSector Rank
P/FCF 49.23
EV/EBITDA 29.19
BX Per share dataBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BX may justify a higher PE ratio.
A more expensive valuation may be justified as BX's earnings are expected to grow with 21.17% in the coming years.
PEG (NY)4.06
PEG (5Y)2.03
EPS Next 2Y19.17%
EPS Next 3Y21.17%

4

5. Dividend

5.1 Amount

BX has a Yearly Dividend Yield of 2.76%.
Compared to an average industry Dividend Yield of 8.21, BX has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, BX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.76%

5.2 History

On average, the dividend of BX grows each year by 11.16%, which is quite nice.
BX has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BX decreased recently.
Dividend Growth(5Y)11.16%
Div Incr Years1
Div Non Decr Years1
BX Yearly Dividends per shareBX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

200.72% of the earnings are spent on dividend by BX. This is not a sustainable payout ratio.
The dividend of BX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP200.72%
EPS Next 2Y19.17%
EPS Next 3Y21.17%
BX Yearly Income VS Free CF VS DividendBX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BX Dividend Payout.BX Dividend Payout, showing the Payout Ratio.BX Dividend Payout.PayoutRetained Earnings

BLACKSTONE INC

NYSE:BX (5/20/2025, 8:04:01 PM)

After market: 144.2 0 (0%)

144.2

-1.25 (-0.86%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-17 2025-04-17/bmo
Earnings (Next)07-16 2025-07-16/amc
Inst Owners70.58%
Inst Owner Change-0.02%
Ins Owners0.77%
Ins Owner Change8.96%
Market Cap176.14B
Analysts75.48
Price Target150.73 (4.53%)
Short Float %1.7%
Short Ratio2.17
Dividend
Industry RankSector Rank
Dividend Yield 2.76%
Yearly Dividend6.1
Dividend Growth(5Y)11.16%
DP200.72%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-28 2025-04-28 (0.93)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.54%
Min EPS beat(2)0.65%
Max EPS beat(2)12.43%
EPS beat(4)3
Avg EPS beat(4)3.56%
Min EPS beat(4)-5.35%
Max EPS beat(4)12.43%
EPS beat(8)4
Avg EPS beat(8)1.84%
EPS beat(12)7
Avg EPS beat(12)2.31%
EPS beat(16)11
Avg EPS beat(16)8.06%
Revenue beat(2)1
Avg Revenue beat(2)2.32%
Min Revenue beat(2)-0.22%
Max Revenue beat(2)4.86%
Revenue beat(4)1
Avg Revenue beat(4)-0.98%
Min Revenue beat(4)-6.69%
Max Revenue beat(4)4.86%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)1
Avg Revenue beat(12)-21.14%
Revenue beat(16)5
Avg Revenue beat(16)18.31%
PT rev (1m)-20.52%
PT rev (3m)-19.08%
EPS NQ rev (1m)-5.67%
EPS NQ rev (3m)-18.4%
EPS NY rev (1m)-5.06%
EPS NY rev (3m)-14.89%
Revenue NQ rev (1m)-2.38%
Revenue NQ rev (3m)-14.45%
Revenue NY rev (1m)-8.1%
Revenue NY rev (3m)-14.56%
Valuation
Industry RankSector Rank
PE 30.36
Fwd PE 21.88
P/S 13.73
P/FCF 49.23
P/OCF 48.24
P/B 22.08
P/tB 29.7
EV/EBITDA 29.19
EPS(TTM)4.75
EY3.29%
EPS(NY)6.59
Fwd EY4.57%
FCF(TTM)2.93
FCFY2.03%
OCF(TTM)2.99
OCFY2.07%
SpS10.5
BVpS6.53
TBVpS4.86
PEG (NY)4.06
PEG (5Y)2.03
Profitability
Industry RankSector Rank
ROA 5.62%
ROE 31.89%
ROCE 19.68%
ROIC 16.42%
ROICexc 18.35%
ROICexgc 19.92%
OM 49.58%
PM (TTM) 19.83%
GM N/A
FCFM 27.89%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
ROICexc(3y)14.24%
ROICexc(5y)19.2%
ROICexgc(3y)15.53%
ROICexgc(5y)21.12%
ROCE(3y)15.37%
ROCE(5y)21.01%
ROICexcg growth 3Y-21.19%
ROICexcg growth 5Y9.44%
ROICexc growth 3Y-21.05%
ROICexc growth 5Y9.86%
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 3.48
Debt/EBITDA 1.95
Cap/Depr 202.82%
Cap/Sales 0.57%
Interest Coverage 14.9
Cash Conversion 57.07%
Profit Quality 140.65%
Current Ratio 0.71
Quick Ratio 0.71
Altman-Z 3.52
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)360.42%
Cap/Depr(5y)264.86%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.63%
Profit Quality(3y)249.28%
Profit Quality(5y)197.86%
High Growth Momentum
Growth
EPS 1Y (TTM)19.95%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%11.22%
EPS Next Y7.48%
EPS Next 2Y19.17%
EPS Next 3Y21.17%
EPS Next 5Y14.46%
Revenue 1Y (TTM)24.23%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%8.41%
Revenue Next Year6.31%
Revenue Next 2Y17.04%
Revenue Next 3Y19.15%
Revenue Next 5Y15.92%
EBIT growth 1Y22.76%
EBIT growth 3Y-19.82%
EBIT growth 5Y13.91%
EBIT Next Year24.73%
EBIT Next 3Y18.9%
EBIT Next 5Y6.22%
FCF growth 1Y-3.07%
FCF growth 3Y-4.46%
FCF growth 5Y12.44%
OCF growth 1Y-7.35%
OCF growth 3Y-4.41%
OCF growth 5Y12.14%